NCT00395343View on ClinicalTrials.gov

Sitagliptin Added-on to Insulin Study (0431-051)

PHASE3CompletedINTERVENTIONAL
Enrollment

641

Participants

Timeline

Start Date

December 11, 2006

Primary Completion Date

October 13, 2008

Study Completion Date

October 13, 2008

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

sitagliptin phosphate

sitagliptin 100 mg tablet qd for a 24-wk treatment period.

DRUG

Comparator : placebo (unspecified)

sitagliptin 100 mg Pbo tablet qd for a 24-wk treatment period.

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00395343 - Sitagliptin Added-on to Insulin Study (0431-051) | Biotech Hunter | Biotech Hunter